Clinical trial
Fourth COVID-19 Vaccine Dose- mRNA1273 - the Sheba HCW Cohort
NCT05230953 is registered in ClinicalTrials.gov with Sheba Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Fourth COVID-19 Vaccine Dose- mRNA1273 - the Sheba HCW Cohort
- Lead sponsor
- Sheba Medical Center
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- January 5, 2022
- Completion date
- July 4, 2024
- Enrollment
- 1,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
covid-19 pandemic